- Report
- December 2023
- 85 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- March 2025
- 42 Pages
Brazil
From €4546EUR$4,995USD£3,897GBP
- Report
- March 2025
- 42 Pages
Japan
From €4546EUR$4,995USD£3,897GBP
- Report
- March 2025
- 43 Pages
China
From €4546EUR$4,995USD£3,897GBP
- Report
- March 2025
- 41 Pages
Russia
From €4546EUR$4,995USD£3,897GBP
- Report
- March 2025
- 42 Pages
Spain
From €4546EUR$4,995USD£3,897GBP
- Report
- March 2025
- 42 Pages
France
From €4546EUR$4,995USD£3,897GBP
- Report
- March 2025
- 41 Pages
Mexico
From €4546EUR$4,995USD£3,897GBP
An intracranial stent is a medical device used to treat conditions such as intracranial stenosis, aneurysms, and arteriovenous malformations. It is a small, flexible tube made of metal or plastic that is inserted into the brain to keep the artery open and allow for improved blood flow. Intracranial stents are typically used in combination with other treatments such as angioplasty, embolization, and endovascular coiling.
The intracranial stent market is a rapidly growing segment of the overall stent market. It is driven by the increasing prevalence of neurological disorders, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to witness a steady growth in the coming years due to the increasing demand for minimally invasive treatments and the growing awareness of the benefits of intracranial stents.
Some of the major companies in the intracranial stent market include Medtronic, Abbott, Johnson & Johnson, Boston Scientific, and Stryker. Show Less Read more